NCT01074099View on ClinicalTrials.gov

Feasibility Study of BMAC Enhanced CABG

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Congestive Heart Failure
Interventions
BIOLOGICAL

BMAC

Injection of BMAC into ischemic myocardium during CABG

PROCEDURE

CABG only

Control subjects will undergo CABG surgery without BMAC injection

Trial Locations (2)

77030

The Methodist Hospital, Houston

84112

University of Utah, Salt Lake City

Sponsors
All Listed Sponsors
collaborator

University of Utah

OTHER

lead

Harvest Technologies

INDUSTRY